Clinical Trial Update: NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

View source ↗

Summary

A clinical trial update reporting on the efficacy of Symbicort SMART in maintaining symptom control for adults with moderate-to-severe asthma. The study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Moderate/Severe Asthma | Status: COMPLETED